Arifa Parker - Infectious Diseases

Author Information

Dr. Arifa Parker is a distinguished researcher associated with the Divisions of General Medicine and Infectious Diseases at the Department of Medicine, Stellenbosch University, and Tygerberg Hospital in Cape Town, South Africa. Her expertise in infectious diseases is evident from her extensive research work, particularly in the context of COVID-19 and related infectious conditions in South Africa.

Research Contributions

Dr. Arifa Parker has made significant contributions to the field of infectious diseases, with a strong focus on COVID-19, its impact, and associated clinical outcomes. Her research spans various critical areas such as the post-COVID-19 condition, the clinical characteristics of candidaemia, and the assessment of the Omicron variant's clinical severity. Her work also includes evaluating the outcomes of SARS-CoV-2 infections across different pandemic waves and exploring risk factors for COVID-19-related mortality in regions with high HIV and tuberculosis prevalence. Dr. Parker's research is crucial in shaping public health strategies and understanding infectious diseases in South Africa.

Aliases

Dr. Arifa Parker is also known by alternative names including A Parker and A. Parker.

Publication and Citation Metrics

Metric	Value
Total Citation Count	973
h-index	11
Total Number of Papers	35

Publications:

Post COVID-19 Condition in South Africa: 3-Month Follow-Up after Hospitalisation with SARS-CoV-2

DOI: 10.2139/ssrn.4007183

Year: 2022

A five-year retrospective descriptive study on the clinical characteristics and outcomes of candidaemia at a tertiary hospital in South Africa

DOI: 10.1016/j.ijregi.2022.03.003

Year: 2022

Spinal nocardiosis: A rare tuberculosis mimic in an HIV infected patient

DOI: 10.1016/j.idcr.2022.e01444

Year: 2022

Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis

DOI: 10.1016/j.ijid.2022.02.051

Year: 2022

SARS-CoV-2 transmission: time to rethink public health strategy

DOI: 10.1016/s1473-3099(22)00137-2

Year: 2022

Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.

DOI: 10.1111/tmi.13752

Year: 2022

Going where the data are: Connecting to Trello for daily statistics in the COVID-19 era and beyond.

DOI: 10.7196/samj.2021.v111i11.16134

Year: 2021

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

DOI: 10.1016/S2352-3018(21)00151-X

Year: 2021

Current Status of Anticoagulation for Hospitalized Patients with Coronavirus Disease 2019 (COVID-19)

DOI: 10.18772/26180197.2021.v3n2a5

Year: 2021

Staff testing for COVID-19 via an online pre-registration form

DOI: 10.4102/sajid.v36i1.232

Year: 2021

What Are the Common Symptoms of Infectious Diseases?

Can Climate Change Affect Food and Water Security?

Who is eligible for Dengvaxia?

What are the Symptoms of Viral Infections?

How Does NAT Work?

Why is MRI Important?

How Effective is Handwashing in Preventing Disease Transmission?

What are the symptoms of Plasmodium falciparum malaria?

What is Disease Eradication?

What Could Be Causing Weight Loss?

Partnered Content Networks

Relevant Topics